<DOC>
	<DOC>NCT02243644</DOC>
	<brief_summary>Comparing the effect of two different duration of same drug albendazole in patients with Neurocysticercosis less than or equal to 5 lesions on CT head at the end of 6 months.</brief_summary>
	<brief_title>Effects of 2 Different Duration of Albendazole Therapy in Patients With Neurocysticercosis in Brain â‰¤ 5 Lesions on CT</brief_title>
	<detailed_description>The trial will be comparing the effectiveness of short and long duration of albendazole ie 7 and 28 days therapy in patients with parenchymal neurocysticercosis in terms of complete resolution or calcification of cyst on CT head at the end of 6 months after starting albendazole</detailed_description>
	<mesh_term>Neurocysticercosis</mesh_term>
	<mesh_term>Cysticercosis</mesh_term>
	<mesh_term>Taeniasis</mesh_term>
	<mesh_term>Albendazole</mesh_term>
	<criteria>Age 218 years. Number of parenchymal lesions: upto 5* Stages of cysticerci at which albendazole treatment is effective Vesicular stage Colloid vesicular stage Granular nodular stage Cysticercotic encephalitis Calcified cyst Hydrocephalus Intraventricular cyst Subarachnoid cyst Ophthalmic Cysticercosis No of cysts &gt;5 Known allergy to benzimidazole class of compound which includes anaphylaxis, hypotension, severe skin reactions . Features of raised ICT (papilloedema, hyperventilation, hypertension, tonic posturing, B/L 6th nerve palsy, features of midline shift on CT/MRI) Critically sick (respiratory failure, cardiovascular instability) Already received albendazole or praziquantel or steroid therapy</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>parenchymal neurocysticercosis upto five lesions</keyword>
</DOC>